시장보고서
상품코드
1302963

세계의 AI를 활용한 Drug Discovery 및 임상시험 시장(2023-2033년)

AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 267 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 AI를 활용한 Drug Discovery·임상시험 시장 규모는 2033년까지 26.5%의 CAGR로 성장할 것으로 예측되고 있습니다. 의료에서 AI 용도의 인지도 향상은 시장의 성장을 촉진하고 있습니다. 그러나 숙련 인재의 부족은 시장의 성장을 억제하고 있는 것으로 생각되고 있습니다.

세계의 AI를 활용한 Drug Discovery·임상시험 시장에 대해 조사했으며, 시장 개요, 시장 분석, 기업 개요 등의 정보를 제공하고 있습니다.

목차

제1장 리포트의 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
    • 공급 기업의 교섭력
    • 구매자의 교섭력
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 신규 진출업체의 위협
  • PEST 분석

제4장 AI를 활용한 Drug Discovery·임상시험 시장 분석 : 컴포넌트별

  • 주요 조사 결과
  • 컴포넌트 부문 : 시장 매력 지수
  • AI를 활용한 Drug Discovery·임상시험 시장 규모 추정과 예측 : 컴포넌트별
  • 서비스
  • 소프트웨어 솔루션

제5장 AI를 활용한 Drug Discovery·임상시험 시장 분석 : 용도별

  • 주요 조사 결과
  • 용도 부문 : 시장 매력 지수
  • AI를 활용한 Drug Discovery·임상시험 시장 규모 추정과 예측 : 용도별
  • 임상시험
  • 약제 설계
  • 데이터 집약과 분석
  • 약제 특징 평가
  • 바이오마커 연구
  • 기타

제6장 AI를 활용한 Drug Discovery·임상시험 시장 분석 : 치료 분야별

  • 주요 조사 결과
  • 치료 분야 부문 : 시장 매력 지수
  • AI를 활용한 Drug Discovery·임상시험 시장 규모 추정과 예측 : 치료 분야별
  • 종양
  • 심혈관질환
  • 감염증
  • 신경변성질환
  • 대사성질환
  • 기타

제7장 AI를 활용한 Drug Discovery·임상시험 시장 분석 : 최종사용자별

  • 주요 조사 결과
  • 최종사용자 부문 : 시장 매력 지수
  • AI를 활용한 Drug Discovery·임상시험 시장 규모 추정과 예측 : 최종사용자별
  • 제약기업 및 바이오의약품 기업
  • 임상시험수탁기관(CRO)(CRO)
  • 기타

제8장 AI를 활용한 Drug Discovery·임상시험 시장 분석 : 지역별

  • 주요 조사 결과
  • 지역 시장 규모 추정과 예측

제9장 북미의 AI를 활용한 Drug Discovery·임상시험 시장 분석

제10장 유럽의 AI를 활용한 Drug Discovery·임상시험 시장 분석

제11장 아시아의 AI를 활용한 Drug Discovery·임상시험 시장 분석

제12장 라틴아메리카의 AI를 활용한 Drug Discovery·임상시험 시장 분석

제13장 중동 및 아프리카의 AI를 활용한 Drug Discovery·임상시험 시장 분석

제14장 기업 개요

  • 경쟁 구도(2022년)
  • 전략 전망
  • IBM Watson
  • Saama Technologies
  • PathAI
  • GNS Healthcare
  • Unlearn.AI, Inc.
  • Novartis AG
  • Merck &Co., Inc.
  • AbbVie Inc.
  • Exscientia

제15장 결론과 권장사항

  • 결론
  • 시장 참여 기업에 대한 권장사항
KSA 23.07.11

The global AI-Enabled Drug Discovery and Clinical Trials market is projected to grow at a CAGR of 26.5% by 2033.

“The AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Awareness of AI applications in Healthcare is Boosting the Market Growth

With the rise of AI applications in healthcare services, people's awareness and acceptance of AI-enabled solutions have grown. More pharmaceutical companies are, therefore, seeking to incorporate these solutions into their drug discovery and clinical trial processes. AI-based drug delivery solutions are becoming increasingly popular in the pharmaceutical industry. These solutions involve using artificial intelligence technologies to develop more efficient and effective drug delivery methods. The use of AI in drug delivery has the potential to transform the industry by reducing costs, improving drug efficacy and safety, and providing better patient outcomes.

The market for AI-based drug delivery solutions is expected to grow in the coming years, with a number of companies already offering or developing such solutions. Some of the key players in this market include:

  • Novartis - Novartis is one of the leading players in the AI-based drug delivery market, with a focus on developing smart inhalers to treat respiratory diseases
  • Medtronic - Medtronic is a medical devices company that is building an AI-based drug delivery platform to improve the delivery of insulin for diabetic patients
  • Insilico Medicine - Insilico Medicine is a drug discovery company that is using AI to develop new drugs and drug delivery methods
  • Johnson & Johnson - Johnson & Johnson is using AI to develop personalized drug delivery solutions, including smart drug-infused contact lenses and implantable drug delivery devices
  • GSK - GSK is using AI to develop inhalers that can adjust the dosage based on the patient's breathing pattern.

As the competition between market players intensifies, companies are investing heavily in research and development to stay ahead of the curve. This is driving innovation and pushing the boundaries of what is possible in the drug delivery industry. In the future, AI-based drug delivery solutions are likely to become increasingly sophisticated, personalized, and targeted, improving patient outcomes and transforming the pharmaceutical industry.

Lack of Skilled Personnel to Hinder the Market Growth

Patient safety is a significant challenge during the drug discovery phase, as activities involving the interpretation of drug effects and anticipation of potential side effects can pose a major constraint on the market. Additionally, the lack of skilled personnel and inadequate datasets for drug discovery and development are crucial factors that may impact market growth. The implementation of AI systems in drug discovery requires companies to possess expertise in system design, management, and implementation. Given the complexity of AI, personnel working with these systems need to have a deep understanding of technologies such as machine learning, deep learning, and other aspects of artificial intelligence. Integrating AI technologies into existing systems to replicate human brain behaviour necessitates substantial data processing. AI/ML development is being restricted owing to lack of professional standards and certifications.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the AI-enabled drug discovery and clinical trials market evolving?
  • What is driving and restraining the AI-enabled drug discovery and clinical trials market?
  • How will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the AI-enabled drug discovery and clinical trials projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?
  • Where is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI-enabled drug discovery and clinical trials market today, and over the next 10 years:

  • Our 267-page report provides 102 tables and 151 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the AI-enabled drug discovery and clinical trials market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-enabled drug discovery and clinical trials prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Component Outlook

  • Services
  • Software

Application

  • Clinical Trials
  • Drug Design
  • Data Aggregation and Analysis
  • Drug Characterization
  • Biomarker Research
  • Others

Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Others

End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • AbbVie Inc
  • Exscientia
  • GNS Healthcare
  • IBM Watson
  • Merck & Co., Inc.
  • Novartis AG
  • PathAI
  • Saama Technologies
  • Unlearn.AI, Inc.

Overall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 in terms of value the market will surpass US$2,156.8 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 Market, with forecasts for component, application, therapeutic area, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 9 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Demand for Personalized Medicine
      • 3.2.1.2 Advancements in Technology
      • 3.2.1.3 Growing Awareness of AI in Healthcare
      • 3.2.1.4 Cost-effectiveness of AI-enabled Solutions
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Lack of Skilled Personnel to Hamper the Market Growth
      • 3.2.2.2 Limited Data Availability is a Major Challenge in Adoption of AI-enabled Solutions
      • 3.2.2.3 Challenges Associated with Integration of New AI-enabled Solution with Existing Infrastructure
      • 3.2.2.4 Ethics and Data Privacy Issues Hindering the Market Growth
      • 3.2.2.5 Regulatory Hurdles Restraining the Global Market Growth
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Improved Patient Outcomes
      • 3.2.3.2 Increased Adoption Of AI-Enabled Solution By Pharma & Biopharma Companies For Clinical Trials
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Components

  • 4.1 Key Findings
  • 4.2 Components Segment: Market Attractiveness Index
  • 4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 4.4 Services
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Software Solutions
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 5.4 Clinical Trials
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Drug Design
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Data Aggregation and Analysis
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Drug Characterization
    • 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)
  • 5.8 Biomarker Research
    • 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.8.2 Market Share by Region, 2023 & 2033 (%)
  • 5.9 Others
    • 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.9.2 Market Share by Region, 2023 & 2033 (%)

6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area

  • 6.1 Key Findings
  • 6.2 Therapeutic Area Segment: Market Attractiveness Index
  • 6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 6.4 Oncology
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Cardiovascular Diseases
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Infectious Diseases
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Neurodegenerative Diseases
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Metabolic Diseases
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Others
    • 6.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)

7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-User

  • 7.1 Key Findings
  • 7.2 End-User Segment: Market Attractiveness Index
  • 7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-User
  • 7.4 Pharmaceutical & Biopharmaceutical Companies
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Contract Research Organizations (CROs)
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Others
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)

8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 9.1 Key Findings
  • 9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis

10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

11 Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 11.3 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Asia AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 11.6 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 11.7 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 11.8 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 11.9 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.10 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.14 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis

12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.12 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

14 Company Profiles

  • 14.1 Company Share Analysis, 2022
  • 14.2 Strategic Outlook
  • 14.3 IBM Watson
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2019 -2022
      • 14.3.3.2 R&D, 2019-2022
      • 14.3.3.3 Regional Market Shares, 2022
    • 14.3.4 Service Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Saama Technologies
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Service Benchmarking
    • 14.4.4 Strategic Outlook
  • 14.5 PathAI
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Service Benchmarking
    • 14.5.4 Strategic Outlook
  • 14.6 GNS Healthcare
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Service Benchmarking
    • 14.6.4 Strategic Outlook
  • 14.7 Unlearn.AI, Inc.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Service Benchmarking
    • 14.7.4 Strategic Outlook
  • 14.8 Novartis AG
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020 -2022
    • 14.8.4 Service Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Merck & Co., Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2019-2021
    • 14.9.4 Service Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 AbbVie Inc.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2019-2021
    • 14.10.4 Service Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Exscientia
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Service Benchmarking
    • 14.11.4 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제